輸入代號或公司名稱後按 Enter
4131

浩泰

+0.70 (+2.24%)最後更新 2026-09-11
台灣 · 上櫃 · 生技醫療業
31.9010成交張數本益比4.45股價淨值比0.00%殖利率2026-09-11資料日期

每股盈餘

柱為單季 EPS,線為近四季合計;近十年

季度單季 EPS年增近四季 EPS歸屬母公司淨利(億)淨利率ROE(季)ROE(近四季)
2026Q2-0.01-103.3%-0.83-0.01-0.7%-0.24%-11.11%
2026Q1-0.05-0.52-0.02-3.0%-0.64%-7.05%
2025Q4-0.35-0.78-0.14-21.1%-4.82%-10.51%
2025Q3-0.42-0.52-0.17-30.2%-5.50%-6.73%
2025Q20.30-0.450.1222.4%3.97%-5.61%
2025Q1-0.31-1.14-0.12-17.6%-4.09%-14.23%
2024Q4-0.09-1.23-0.04-30.3%-1.14%-14.75%
2024Q3-0.35-1.68-0.14-84.8%-4.41%-19.18%
2024Q2-0.39-1.84-0.15-85.3%-4.59%-19.87%
2024Q1-0.40-1.82-0.16-98.7%-4.56%-19.17%
2023Q4-0.54-1.87-0.21-112.1%-5.75%-30.52%
2023Q3-0.51-1.65-0.19-138.1%-5.12%-21.91%
2023Q2-0.37-1.58-0.15-120.2%-3.85%-16.11%
2023Q1-0.45-1.73-0.10-48.3%-3.99%-13.25%
2022Q4-0.32-1.49-0.06-22.0%-7.31%-30.02%
2022Q3-0.44-1.86-0.08-39.3%-8.80%-27.54%
2022Q2-0.52-1.51-0.10-86.3%-9.63%-22.49%
2022Q1-0.21-1.07-0.04-13.7%-3.58%-15.85%
2021Q4-0.69-0.91-0.07-25.0%-5.69%-14.25%
2021Q3-0.09-0.37-0.04-24.1%-3.67%-14.28%
2021Q2-0.08-0.37-0.04-19.0%-2.93%-13.98%
2021Q1-0.05-0.41-0.03-10.1%-1.98%-15.00%
2020Q4-0.15-0.56-0.07-30.0%-5.50%-19.40%
2020Q3-0.09-280.0%-0.57-0.05-18.2%-3.55%-19.12%
2020Q2-0.12-0.43-0.06-25.1%-4.13%-13.94%
2020Q1-0.20-0.38-0.10-45.4%-6.60%-12.02%
2019Q4-0.16-0.25-0.08-28.1%-4.90%-7.61%
2019Q30.05-0.250.0310.0%1.67%-7.47%
2019Q2-0.07-0.42-0.03-14.6%-2.20%-12.42%
2019Q1-0.07-0.48-0.03-12.4%-2.18%-13.79%
2018Q4-0.16-0.54-0.08-36.1%-4.76%-17.94%
2018Q3-0.12-0.52-0.06-21.3%-3.31%-15.24%
2018Q2-0.13-0.53-0.06-64.4%-3.56%-14.37%
2018Q1-0.13-0.56-0.05-165.1%-3.37%-13.64%
2017Q4-0.14-0.56-0.05-243.9%-4.26%-16.66%
2017Q3-0.13-0.65-0.05-203.4%-4.22%-18.54%
2017Q2-0.16-0.71-0.06-145.3%-4.68%-19.06%
2017Q1-0.13-0.73-0.05-145.5%-3.54%-18.72%
2016Q4-0.23-0.73-0.09-213.2%-6.16%
2016Q3-0.19-0.07-159.3%-4.73%